Results 11 to 20 of about 299,566 (148)
Pediatric Neurology Briefs, 1990 Three infants with a relapsing form of infant botulism are reported from the Division of Child Neurology, The Children’s Hospital of Philadelphia, PA.
J Gordon Millichap
doaj +2 more sources
Abnormal neuroimaging in a case of infant botulism [PDF]
Frontiers in Pediatrics, 2015 We present the first case of abnormal neuroimaging in a case of infant botulism. The patient presented with clinical findings of constipation, bulbar weakness and descending, symmetric motor weakness which are consistent with the classic findings of ...
Ryan J Good +4 more
doaj +4 more sources
Infant Botulism and Honey [PDF]
EDIS, 2009 Revised! ENY128, a 2-page fact sheet by Malcolm T. Sanford, Eddie Atkinson, and Jamie Ellis, prepares beekeepers to answer questions responsibly about honey as a potential source of C. botulinum spores, which can cause botulism in infants under 12 months
Malcolm T. Sanford +2 more
doaj +7 more sources
Zdravniški Vestnik, 2013 Infant botulism is a potentially fatal disease, caused by neurotoxigenic strain of Clostridium botulinum that colonizes infant’s gut. The incidence of the disease is low, but is probably underestimated in Europe.
Anja Radšel +4 more
doaj +1 more source
Infant Botulism in the Very Young Neonate: A Case Series
American Journal of Perinatology Reports, 2017 Background Though botulism is a rare disease overall, all infants younger than 1 year of age are at risk of contracting infant botulism, the most prevalent form reported in the United States.
Laura Jackson +4 more
doaj +2 more sources
Trial of Immune Globulin in Infant Botulism
Pediatric Neurology Briefs, 2006 A 5-year, randomized, double-blind, placebo-controlled trial of the orphan drug Human Botulism Immune Globulin Intravenous (BIG-IV) in 122 infants in California with confirmed infant botulism (75 caused by type A Clostridium botulinum toxin, and 47 by ...
J Gordon Millichap
doaj +2 more sources
Clinical Case ReportsIn infant botulism, use of equine‐derived botulinum antitoxin before BIG‐IV may be clinically justified when the infant‐specific product is delayed.
Muhammad Abdullah Awan +1 more
doaj +2 more sources
Diagnosis and Treatment of Infant Botulism
Pediatric Neurology Briefs, 2005 The clinical presentation, diagnosis, and treatment of infant botulism (IB) are reviewed by investigators at the University of California-San Francisco, CA.
J Gordon Millichap
doaj +2 more sources
The Eurasian Journal of Medicine, 2010 Infant botulism is a rare condition caused by intestinal colonization with Clostridium botulinum. The enteric toxin causes intestinal immobility and progressive descending paralysis due to the effect on acetylcholine release at the neuromuscular junction and other cholinergic nerve terminals, particularly in the gut.
Eren, Cagan +3 more
openaire +3 more sources
Toxemia in Human Naturally Acquired Botulism
Toxins, 2020 Human botulism is a severe disease characterized by flaccid paralysis and inhibition of certain gland secretions, notably salivary secretions, caused by inhibition of neurotransmitter release.
Christine Rasetti-Escargueil +2 more
doaj +1 more source